Drug
Tight blood pressure management
Tight blood pressure management is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
50%
Ph phase_4
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 4Post-market surveillance
2(50.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(3)
Completed(1)
Detailed Status
Enrolling by invitation2
Completed1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 42 (50.0%)
N/A2 (50.0%)
Trials by Status
completed125%
enrolling_by_invitation250%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
recruitingnot_applicable
The GUARDIAN Trial
NCT04884802
enrolling_by_invitationphase_4
The GUARDIAN Trial - Vasopressor Sub-Study
NCT04934748
enrolling_by_invitationphase_4
The GUARDIAN Trial - Induction Agent Sub-Study
NCT04934683
completednot_applicable
Biomarkers, Blood Pressure, BIS: Risk Stratification/Management of Patients at Cardiac Risk in Major Noncardiac Surgery
NCT02533128
Clinical Trials (4)
Showing 4 of 4 trials
NCT04884802Not Applicable
The GUARDIAN Trial
NCT04934748Phase 4
The GUARDIAN Trial - Vasopressor Sub-Study
NCT04934683Phase 4
The GUARDIAN Trial - Induction Agent Sub-Study
NCT02533128Not Applicable
Biomarkers, Blood Pressure, BIS: Risk Stratification/Management of Patients at Cardiac Risk in Major Noncardiac Surgery
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4